Article

Gregory J. Riely on the Identification and Treatment of MET Exon 14 Skipping Mutations

Author(s):

Gregory J. Riely

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Josh Sabari and Terri Conneran
Dr. Rosario Ligestri
image of man.
Related Content
Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!
September 17th 2025

What the Changing Seasons Taught Me About Cancer and Life

Tamron Little
CURE Cancer Horizons logo
September 17th 2025

FDA Approvals from February 2024

Alex Biese Brielle Benyon
Lutathera demonstrated antitumor activity in metastatic bronchopulmonary neuroendocrine tumors: © stock.adobe.com.
September 17th 2025

Real-World Study Finds Benefit of Lutathera in Patients With Lung NETs

Ashley Chan
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
September 17th 2025

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Sue McCarthy received diagnoses of breast cancer in 2001 and lung cancer in 2018. Catch up on all of Sue's blogs here!
September 17th 2025

Standing Up to a Friend’s Cancer Is as Hard as Facing My Own

Sue McCarthy
Image of a head and neck
September 17th 2025

Understanding Head and Neck Cancer: A Guide for Newly Diagnosed Patients

Gina Mauro